Literature DB >> 19304100

Induction of apoptosis of rabbit corneal endothelial cells by preservative-free lidocaine hydrochloride 2%, ropivacaine 1%, or levobupivacaine 0.75%.

Mehmet Borazan1, Aylin Karalezli, Sibel Oto, Yonca Aydin Akova, Gulten Karabay, Alper Kocbiyik, Bulent Celasun, Beyhan Demirhan.   

Abstract

PURPOSE: To determine and compare the amount of apoptosis and changes in rabbit corneal endothelial cell morphology after intracameral administration of different anesthetic agents.
SETTING: Department of Ophthalmology, Baskent University Medical Faculty, Ankara, Turkey.
METHODS: Right eyes of 64 Vienna white rabbits were injected intracamerally with preservative-free lidocaine hydrochloride 2%, ropivacaine 1%, levobupivacaine 0.75%, or fortified balanced salt solution (BSS Plus) (control). Animals were humanely killed 1 day or 7 days later. Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling was used to detect apoptosis. Corneal endothelial cells and apoptotic cells were counted by light microscopy. The morphologic appearance was determined by transmission electron microscopy (TEM).
RESULTS: Apoptotic cell density was high in the anesthetic groups on day 1 (P<.01); there was no significant difference between groups at 7 days. Apoptotic cell density declined significantly between 1 day and 7 days in the anesthetic groups (P<.05) but not in the control group. There was no difference in endothelial cell density between the 4 groups at 1 or 7 days. All anesthetic groups showed degenerative changes on TEM, with the least change in the preservative-free lidocaine hydrochloride 2% group.
CONCLUSIONS: Intracameral injections of preservative-free lidocaine, ropivacaine, and levobupivacaine induced significantly more apoptotic endothelial cell loss than BSS Plus and led to morphologic changes in the corneal endothelial cells in the early period. This effect was temporary, with recovery by 7 days. Considering the limited proliferative capacity in human eyes, the induced apoptosis might result in the permanent cell loss and enlargement in human corneal endothelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304100     DOI: 10.1016/j.jcrs.2008.12.016

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  The unfolded protein response in human corneal endothelial cells following hypothermic storage: implications of a novel stress pathway.

Authors:  William L Corwin; John M Baust; John G Baust; Robert G Van Buskirk
Journal:  Cryobiology       Date:  2011-04-28       Impact factor: 2.487

2.  Increased Oxidative Damage and Reduced DNA Repair Enzyme XPD Involvement in High Glucose-Mediated Enhancement of Levobupivacaine-Induced Neurotoxicity.

Authors:  ZhongJie Liu; Wei Zhao; QingGuo Zhang; LuYing Lai; Shan Jiang; Jing Zhang; ShiYuan Xu
Journal:  Neurochem Res       Date:  2015-08-12       Impact factor: 3.996

3.  Cataract surgery complications: an in vitro model of toxic effects of ropivacaine and lidocaine.

Authors:  Nicola Pescosolido; Gianfranco Scarsella; Marco Tafani; Marcella Nebbioso
Journal:  Drugs R D       Date:  2011-12-01

4.  Sodium Ferulate Attenuates Lidocaine-Induced Corneal Endothelial Impairment.

Authors:  Guojian Jiang; Tingjun Fan
Journal:  Oxid Med Cell Longev       Date:  2018-07-08       Impact factor: 6.543

5.  Comparative clinical trial of intracameral ropivacaine vs. lignocaine in subjects undergoing phacoemulsification under augmented topical anesthesia.

Authors:  Arun K Sharma; Shalini Singh; Sanjeev Hansraj; Ajai K Gupta; Siddharth Agrawal; Vishal Katiyar; Sanjiv K Gupta
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

6.  [The chondrotoxic and apoptotic effects of levobupivacaine and bupivacaine on the rabbit knee joint].

Authors:  Osman Çevik; Özlem Öz Gergin; Karamehmet Yildiz; Adnan Bayram; Özlem Canöz; Mehmet Halici; Münevver Baran; Arzu Yay; Sait Polat
Journal:  Braz J Anesthesiol       Date:  2018-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.